The three team finalists were: George: Katie Depue, David Koellhofer, and Brendan Reilly. Deliberate: Marc Aafjes, Michael Balangue, Do Hyung Kwon, Hansaim Lim, and Paulo Serodio. Deep Brain Precision: John Di Capua, Taylor Miller, Ashley So, and Danielle Soldin.
One hundred eighty medical and graduate students, and others, formed 19 teams to participate in the fourth annual Mount Sinai Health Hackathon in October. The 48-hour competition, held over the weekend leading up to the SinaInnovations Conference, challenged the participants to create novel health care solutions that would expand the limits of human performance.
Three teams each received checks totaling $2,500 and will have the opportunity to pitch their ideas again in 2020 at Mount Sinai’s Innovation Showcase before a group of entrepreneurs and venture capitalists. They will be joined by a fourth wild-card team chosen from the non-finalists.
Scott L. Friedman, MD, Dean for Therapeutic Discovery, and Chief of the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, told the participants, “We started this event four years ago as part of a larger effort to spur innovation. This is really the embodiment of our values about teamwork and doing great things.”
The three team finalists were:
Deliberate: Improving the quality of care in psychotherapy through confidential recording and analysis. Team members: Marc Aafjes, Michael Balangue, Do Hyung Kwon, Hansaim Lim, and Paulo Serodio.
George: An artificial intelligence application that allows dialysis providers to optimize scheduling and improve a clinic’s efficiency. Team members: Katie Depue, David Koellhofer, and Brendan Reilly.
Deep Brain Precision: An app that would allow physicians to monitor a patient’s progress after receiving deep brain stimulation for Parkinson’s disease and other motor disorders. Team members: John Di Capua, Taylor Miller, Ashley So, and Danielle Soldin.
Sponsors and partners: Accenture; Altice Business; Cisco; Farmer’s Fridge; Kitware; PepsiCo; Persistent Systems; the National Center for Advancing Translational Sciences, National Institutes of Health; and the Christopher & Dana Reeve Foundation.